Ascorbic acid inhibition of cytochrome P450-catalyzed uroporphyrin accumulation - PubMed (original) (raw)
. 1993 Aug 1;304(2):464-70.
doi: 10.1006/abbi.1993.1376.
Affiliations
- PMID: 8346921
- DOI: 10.1006/abbi.1993.1376
Ascorbic acid inhibition of cytochrome P450-catalyzed uroporphyrin accumulation
P R Sinclair et al. Arch Biochem Biophys. 1993.
Abstract
Previous studies on the mechanism of the uroporphyria caused by polyhalogenated aromatic hydrocarbons have indicated a key role of cytochrome P450 of the 1A subfamily in catalyzing uroporphyrinogen (UROgen) oxidation. Here we report that ascorbic acid (ASC) inhibits UROgen oxidation in primary cultures of chick embryo hepatocytes and hepatic microsomes from chickens and mice. In hepatocyte cultures, 0.15 mM ASC totally prevented the accumulation of uroporphyrin (URO) induced by treatment of cells with the combination of 3,4,3',4'-tetrachlorobiphenyl (TCB) and 2-propyl-2-isopropylacetamide (PIA), but had no effect on the induction of protoporphyrin accumulation by PIA and desferrioxamine. However, addition of 5-aminolevulinic acid (ALA) to cultures treated with PIA plus TCB decreased the ability of ASC to prevent URO accumulation, suggesting that the effectiveness of ASC was dependent on the intracellular concentration of ALA or its metabolites. Similarly, when chick hepatocyte cultures were treated with TCB plus exogenous ALA to produce URO accumulation, the effectiveness of ASC was also less than when ALA was produced endogenously. Under this condition, addition of piperonyl butoxide, a P450 inhibitor, increased ASC inhibition of URO accumulation. ASC competitively inhibited the oxidation of UROgen by hepatic microsomes from chicks or mice treated with 3-methylcholanthrene (MC) with Ki for ASC being about 0.1 mM. ASC prevented formation of a 500-nm absorbing compound, probably tetrahydrouroporphyrin, the first intermediate in UROgen oxidation. These results are consistent with ASC preventing URO accumulation in hepatocytes by competitive inhibition of the first step of UROgen oxidation and suggest a new physiological role of ASC, that of maintaining UROgen in the reduced state.
Similar articles
- Ascorbic acid inhibits chemically induced uroporphyria in ascorbate-requiring rats.
Sinclair PR, Gorman N, Sinclair JF, Walton HS, Bement WJ, Lambrecht RW. Sinclair PR, et al. Hepatology. 1995 Aug;22(2):565-72. Hepatology. 1995. PMID: 7635426 - Multiple roles of polyhalogenated biphenyls in causing increases in cytochrome P450 and uroporphyrin accumulation in cultured hepatocytes.
Sinclair PR, Walton HS, Gorman N, Jacobs JM, Sinclair JF. Sinclair PR, et al. Toxicol Appl Pharmacol. 1997 Dec;147(2):171-9. doi: 10.1006/taap.1997.8273. Toxicol Appl Pharmacol. 1997. PMID: 9439713 - Identification of CYP1A5 as the CYP1A enzyme mainly responsible for uroporphyrinogen oxidation induced by AH receptor ligands in chicken liver and kidney.
Sinclair PR, Gorman N, Walton HS, Sinclair JF, Lee CA, Rifkind AB. Sinclair PR, et al. Drug Metab Dispos. 1997 Jul;25(7):779-83. Drug Metab Dispos. 1997. PMID: 9224771 - Cytochrome P450 and its interactions with the heme biosynthetic pathway.
De Matteis F, Marks GS. De Matteis F, et al. Can J Physiol Pharmacol. 1996 Jan;74(1):1-8. Can J Physiol Pharmacol. 1996. PMID: 8963944 Review. - Oxidative injury mediated by the hepatic cytochrome P-450 system in conjunction with cellular iron. Effects on the pathway of haem biosynthesis.
Smith AG, De Matteis F. Smith AG, et al. Xenobiotica. 1990 Sep;20(9):865-77. doi: 10.3109/00498259009046902. Xenobiotica. 1990. PMID: 2238708 Review.
Cited by
- Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.
Egger NG, Goeger DE, Payne DA, Miskovsky EP, Weinman SA, Anderson KE. Egger NG, et al. Dig Dis Sci. 2002 Feb;47(2):419-26. doi: 10.1023/a:1013746828074. Dig Dis Sci. 2002. PMID: 11855561 - Turnabout is fair play: Secondary roles for primary compounds.
Berenbaum MR. Berenbaum MR. J Chem Ecol. 1995 Jul;21(7):925-40. doi: 10.1007/BF02033799. J Chem Ecol. 1995. PMID: 24234410 - NADPH-initiated cytochrome P450-dependent free iron-independent microsomal lipid peroxidation: specific prevention by ascorbic acid.
Ghosh MK, Mukhopadhyay M, Chatterjee IB. Ghosh MK, et al. Mol Cell Biochem. 1997 Jan;166(1-2):35-44. doi: 10.1023/a:1006841228483. Mol Cell Biochem. 1997. PMID: 9046019 - Role of Vitamin C in Skin Diseases.
Wang K, Jiang H, Li W, Qiang M, Dong T, Li H. Wang K, et al. Front Physiol. 2018 Jul 4;9:819. doi: 10.3389/fphys.2018.00819. eCollection 2018. Front Physiol. 2018. PMID: 30022952 Free PMC article. Review. - A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda.
Phillips JD, Bergonia HA, Reilly CA, Franklin MR, Kushner JP. Phillips JD, et al. Proc Natl Acad Sci U S A. 2007 Mar 20;104(12):5079-84. doi: 10.1073/pnas.0700547104. Epub 2007 Mar 9. Proc Natl Acad Sci U S A. 2007. PMID: 17360334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous